Discovery Park success recognised at 2015 Estates Gazette awards

The negotiations that led to an Australian fertility technologies company, Genea deciding to locate its European headquarters at Discovery Park have been recognised at a top industry awards evening.

The Estates Gazette Awards celebrate achievements in the property market, with a judging panel made of leading industry expers with Discovery Park named runner-up in the Deal of the Year category at a glittering ceremony held last night (10/12) at the London Hilton Hotel.

Anna Stone, Leasing Director, Discovery Park, said: “We were delighted to be nominated for this award and, while we would have loved to have won, it’s great to be recognised for what we do.  

“I am incredibly proud of all the team here. Their dedication and hard work over the past three years have helped to build Discovery Park into the success it has become.”

The 220 acre site was acquired by Discovery Park Limited in 2012. Keen to preserve and build upon the site’s heritage, its owners have created an attractive community which, since purchase, has attracted international companies from Australia to India, including: Genea, Mylan and Quvium.

With just five tenants when it was acquired, Discovery Park is now home to over 120 businesses. Today the park is home to companies from a wide variety of sectors, including life science companies, technology firms, educational facilities and business services companies. Collectively these businesses employ more than 2,300 people.

Genea’s move to Discovery Park last summer followed more than a year of negotiation with the bio-tech company ultimately discounting other technology hubs, such as Oxford and Cambridge in favour of Sandwich.

The company credited the support of Discovery Park and a host of businesses on site for their part in sealing the deal – from accountants and lawyers to brand and recruitment consultants. All of the company’s support team came from Discovery Park tenants, 

Genea’s fertility technologies company Genea Biomedx and stem cell company Genea Biocells now use the site to manufacture culture medium, for distribution to Europe, where some 40 per cent of the world’s IVF clinics are located.

Posted on 14/12/2015